Irbesartan hydrochloride

CellPrime&#174 rLR3 IGF is a is a non-animal origin (NAO) recombinant equivalent Insulin-like growth factor expressed in E.coli.

This reagent set contains Lovibond&#39s Powder Pack&trade Reagents. Powder Pack Reagents are pre-measured, unit dose reagents that have been formulated for use in Lovibond&#39s Aqua Comparator Test Kits, the SC450 Single Parameter Colorimeter

Analysis Note Hydroxyl value: 1190 - 1320 Melting range (lower value): &#8805 208 &#176C Melting range (upper value): &#8804 218 &#176C Identity (IR): passes test

A potent inhibitor of ROCK-II, PRK-2, MSK1, and MAPKAP-K1b with IC50 values of 1.9, 4, 5, and 15 &microM, respectively has been shown to reduce blood vessel constriction, decreases pulmonary arterial pressure, inhibit tumor angiogenesis, and

A potent inhibitor of ROCK-II, PRK-2, MSK1, and MAPKAP-K1b with IC50 values of 1.9, 4, 5, and 15 &microM, respectively has been shown to reduce blood vessel constriction, decreases pulmonary arterial pressure, inhibit tumor angiogenesis, and

A potent inhibitor of ROCK-II, PRK-2, MSK1, and MAPKAP-K1b with IC50 values of 1.9, 4, 5, and 15 &microM, respectively has been shown to reduce blood vessel constriction, decreases pulmonary arterial pressure, inhibit tumor angiogenesis, and

Mouse anti Human Integrin beta 3/CD61 Antibody, Monoclonal (HIP11), could be used for Flow and so on.Application:Flow:Protein FunctionIntegrin alpha-V/beta-3 is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2,

Application Irbesartan USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Analysis Note These products are for test and assay use only.

General description Irbesartan is a potent, long-acting “sartan” class, nonpeptide, angiotensin II receptor antagonist utilized for the management of hypertension as well as heart failure in clinical patients. It shows high selectivit

Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.An angiotensin II type 1 (AII1)-receptor antagonist.

An angiotensin II receptor blocker with a high affinity for the AT1 receptor (Ki = 2.7 nM) and exceptionally high bioavailability (60-80%) an insurmountable antagonist of AT1 act as a cardiovascular protective agent by effectively reducing blood

An angiotensin II receptor blocker with a high affinity for the AT1 receptor (Ki = 2.7 nM) and exceptionally high bioavailability (60-80%) an insurmountable antagonist of AT1 act as a cardiovascular protective agent by effectively reducing blood